A new study, released on the bioRxiv* preprint server, shows that rapamycin, an immunosuppressive drug used in some cancers, and
Continue reading »
mypharmacynews.com
Home » Sars-CoV-2 »
A new study, released on the bioRxiv* preprint server, shows that rapamycin, an immunosuppressive drug used in some cancers, and
Continue reading »By investigating antibody and T cell responses to a single dose of the Oxford–AstraZeneca COVID-19 vaccine, researchers from Sri Lanka
Continue reading »It is an open question to what extent protection against reinfection persists after overcoming a SARS-CoV-2 infection. The “Rhineland Study”,
Continue reading »A study conducted at the University of Campinas (UNICAMP) in the state of São Paulo, Brazil, shows that compounds produced
Continue reading »Several severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern are characterized by mutations in the receptor-binding domain and
Continue reading »Several severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern are characterized by mutations in the receptor-binding domain and
Continue reading »(HealthDay)—Community exposures, but not workplace factors, are associated with seropositivity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among health
Continue reading »That Sen. Rand Paul of Kentucky often disagrees with infectious-disease expert Dr. Anthony Fauci is well known. Recently, the pair
Continue reading »The current COVID-19 outbreak is one of the worst pandemics in history and has claimed millions of lives across the
Continue reading »Scientists have found new, unexpected behaviors when SARS-CoV-2—the virus that causes COVID-19—encounters drugs known as inhibitors, which bind to certain
Continue reading »